New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...
Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to ...
Wellbeing Magazine on MSN
Full body health check-up in Turkey: Comprehensive screening at Liv Hospital
When Mehmet, a 52-year-old engineer from Amsterdam, landed in Istanbul for what he thought would be a routine business trip, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results